3.0.0 581 2019-11-15T21:52:35Z 2019-11-15T21:52:35Z Senate S S 2005-03-09 109 ssfi00 Finance Committee Senate Standing Referred to 2005-03-09T22:21:19Z Medicare Prescription Drug Cost Containment Act of 2005 109 918 HR 2005-03-14 Referred to the Subcommittee on Health. Related bill CRS 2005-03-09 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2005-03-09 Introduced in Senate IntroReferral 10000 9 Library of Congress G000359 Sen. Graham, Lindsey [R-SC] Lindsey Graham R SC N S001141 Sen. Sessions, Jeff [R-AL] Jeff Sessions R AL 2005-03-09 True Health Budget surpluses Commerce Congress Congressional reporting requirements Drugs Economics and Public Finance Expedited congressional procedure Government trust funds House rules and procedure Legislation Medicare Prescription pricing Senate rules and procedure Social Welfare Health 00 2005-03-09 Introduced in Senate 2005-04-11T20:43:13Z Medicare Prescription Drug Cost Containment Act of 2005 - Directs the Secretary of Health and Human Services, on the same date on which the President submits a budget to Congress, to submit to Congress a determination on the following: (1) whether there is projected to be excess general revenue Medicare prescription drug funding for the fiscal year for which the budget is submitted; or (2) whether there was excess general revenue Medicare prescription drug funding in the prior fiscal year. States that, if there is an affirmative determination on either question, it shall be treated as a Medicare part D (Voluntary Prescription Drug Benefit Program) funding warning in the fiscal year during which the determination is submitted to Congress.

Amends Federal money and finance law, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to direct the President to submit to Congress, within 15 days after the budget submission, proposed legislation to respond to such a Medicare part D funding warning. States that such requirement shall not apply if, during the year in which the warning is made, legislation is enacted which eliminates excess general revenue Medicare funding for the period beginning with the fiscal year for which the determination is made and ending on September 30, 2013.

Expresses the sense of Congress that any such submitted legislation should be designed to eliminate excess general revenue Medicare funding for such period.

Sets out the special procedures for House and Senate consideration of the President's legislative proposal in response to such a warning.

]]> Medicare Prescription Drug Cost Containment Act of 2005 Short Titles as Introduced Medicare Prescription Drug Cost Containment Act of 2005 Display Title Medicare Prescription Drug Cost Containment Act of 2005 Official Title as Introduced A bill to contain the costs of the medicare prescription drug program under part D of title XVIII of the Social Security Act, and for other purposes. Introduced in Senate 2005-03-09T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109s581is/xml/BILLS-109s581is.xml 2005-03-09 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.